Singapore markets closed

USB Jan 2025 27.500 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.21000.0000 (0.00%)
At close: 02:04PM EDT
Full screen
Previous close0.2100
Expiry date2025-01-17
Day's range0.2100 - 0.2200
Contract rangeN/A
Open interest3.74k

    Director Aleem Gillani Buys 10,000 Shares of U.S. Bancorp (USB)

    U.S. Bancorp, a major financial services company, provides various banking and financial products and services in the United States. The company's services include lending and depository services, cash management, foreign exchange, and trust and investment management services. The price-earnings ratio of U.S. Bancorp is 14.10, which is above the industry median of 10.12.

  • Thomson Reuters StreetEvents

    Q2 2024 US Bancorp Earnings Call

    Q2 2024 US Bancorp Earnings Call

  • Yahoo Finance Video

    China chip exports, Fed rate cut optimism: Market Domination

    The tech-heavy Nasdaq Composite (^IXIC) and S&P 500 (^GSPC) are taking hits leading into the final trading hour of Wednesday, July 17, in connection to a selloff by semiconductor companies. Julie Hyman and Josh Lipton bring on the leading experts and market strategists to talk about where the market is headed and how US-China trade relations could impact growth. Yardeni Research President Ed Yardeni joins the program to discuss movements in small and mid cap stocks, touching on which direction tech sector trends could move in based on the Federal Reserve's commitment to interest rate cuts. KraneShares Managing Director David Adelman, who also served as the US ambassador to Singapore, comments on the role stricter US export controls could have on pushing China to possibly "accelerate... development of its ecosystem." Wedbush Securities SVP of equity research Matt Bryson believes the US-China trade policies won't have much effect on chipmakers like Nvidia (NVDA). Other top trending tickers on the Yahoo Finance platform include Tesla (TSLA), Charles Schwab (SCHW), JB Hunt Transport Services (JBHT), and Johnson & Johnson (JNJ) after the pharma giant reported a second-quarter beat on earnings estimates. This post was written by Luke Carberry Mogan.